Antagonist Treatment | [3H]Dopamine Release |
---|---|
% 25 μM AnTx-a control1-a | |
None | 100.0 |
α-Bgt (40 nM) | 60.2 ± 15.6 (n = 8) |
MLA (50 nM) | 68.7 ± 9.0 (n = 7) |
αCtx-MII (112 nM) | 70.9 ± 4.8 (n = 4) |
α-Bgt + DNQX (100 μM) | 61.1 ± 9.6 (n = 5) |
MLA + DNQX (100 μM) | 67.3 ± 11.9 (n = 3) |
α-Bgt + αCtx-MII | 27.4 ± 18.0 (n = 5)1-150 |
MLA + αCtx-MII | 28.7 ± 2.5 (n = 3)1-160 |